1. Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
   Jochen Belmans et al, 2017, Scientific Reports CrossRef
2. Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
   null Schirrmacher et al, 2019, Biomedicines CrossRef
3. Treatment of Pelvic and Spinal Bone Metastases: Radiotherapy and Hyperthermia Alone vs. in Combination
   Jong-Hun Kim et al, 2024, Cancers CrossRef
4. Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
   Volker Schirrmacher et al, 2015, Immunotherapy CrossRef
5. The Oncolytic Herpes Simplex Virus Talimogene Laherparepvec Shows Promising Efficacy in Neuroendocrine Cancer Cell Lines
   Linus D. Kloker et al, 2019, Neuroendocrinology CrossRef
6. Cancer-reactive memory T cells from bone marrow: Spontaneous induction and therapeutic potential (Review)
   VOLKER SCHIRRMACHER, 2015, International Journal of Oncology CrossRef
7. Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy
   Jason P. Knapp et al, 2022, Biomedicines CrossRef
8. Making Oncolytic Virotherapy a Clinical Reality: The European Contribution
   Margaret R. Duffy et al, 2017, Human Gene Therapy CrossRef
9. Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!
   Volker Schirrmacher, 2016, Biomedicines CrossRef
10. Durchbrechen von Therapieresistenzen
    Volker Schirrmacher, 2015, Wiener klinisches Magazin CrossRef
11. Potentiating prostate cancer immunotherapy with oncolytic viruses
    Patrick Lee et al, 2018, Nature Reviews Urology CrossRef
12. Exploring the role of oncolytic viruses in hepatobiliary cancers
    Pavan Tenneti et al, 2018, Immunotherapy CrossRef
13. Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
    Stefaan W. Van Gool et al, 2020, Cancers CrossRef
14. Modulated Electrohyperthermia: A New Hope for Cancer Patients
    Huda F. Alshaibi et al, 2020, BioMed Research International CrossRef
15. Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical
    Chao Tang et al, 2022, Clinical and Translational Oncology CrossRef
16. Remarkable Pathologic Change in Advanced Prostate Cancer Patient Using Dendritic Cell–Cytokine-Induced Killer Combined Therapy: A Case Report
    Peng Xu et al, 2015, Clinical Genitourinary Cancer CrossRef
17. Low-frequency ultrasound-induced VEGF suppression and synergy with dendritic cell-mediated anti-tumor immunity in murine prostate cancer cells in vitro
    Wei Zhang et al, 2017, Scientific Reports CrossRef
18. Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit
    Volker Schirrmacher et al, 2020, Biomedicines CrossRef
19. Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
    Volker Schirrmacher, 2017, International Journal of Molecular Sciences CrossRef
20. Recurrent scrotal edema in a patient with radiation enteritis: A case report
    SHENGXIAN FAN et al, 2016, Molecular and Clinical Oncology CrossRef
21. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance
    Volker Schirrmacher, 2015, Expert Opinion on Biological Therapy CrossRef